Treating ROP: how and when
نویسندگان
چکیده
Laser treatment The mainstay of treatment for severe ROP is peripheral retinal photocoagulation, delivered by laser. Only the avascular retinal periphery should be treated. The laser burns should be light and almost confluent (Figure 1). Laser treatment requires a trained and highly skilled ophthalmologist. Treatment is painful and should be given under topical anaesthesia with or without sedation, or under general anaesthesia. It is essential that the infant is monitored closely during treatment. A neonatologist or trained neonatal nurse must be present.
منابع مشابه
The Incidence and Risk Factors of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants in Turkey
BACKGROUND The aim of this study was to identify the incidence of severe retinopathy of prematurity (ROP) requiring laser treatment and the overall incidence of ROP in extremely low birth weight (ELBW) infants, and to evaluate the associated risk factors for developing severe ROP in ELBW infants in Turkey. MATERIAL AND METHODS This retrospective, case-control, tertiary care-hospital based stu...
متن کاملIntravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.
OBJECTIVES Laser therapy is effective in the treatment of severe forms of retinopathy of prematurity (ROP), and aggressive posterior ROP (APROP), but always damages the retina. We report our preliminary findings in seven premature infants with complicated ROP or APROP who were treated with intravitreal bevacizumab (IVB) as first line monotherapy or rescue therapy combined with laser treatment. ...
متن کاملThe Cell-Matrix Interface: a Possible Target for Treating Retinal Vascular Related Pathologies
Retinal vasculature related pathologies account for a large proportion of global blindness. Choroidal neovascularization accompanying age-related macular degeneration is the largest cause of blindness in people over the age of 65 years, proliferative diabetic retinopathy is the main cause of acquired blindness in working adults, and retinopathy of prematurity (ROP) is the leading cause of acqui...
متن کاملHypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.
Intravitreal bevacizumab therapy in preterm infants for retinopathy of prematurity (ROP) can be associated with hypotension. We report twin preterm infants who developed hypotension within 1 day after intravitreal bevacizumab therapy for ROP. Before receiving the medication, their clinical statuses were stable and similar. The dose, procedure, and premedication were the same; however, twin B pr...
متن کاملA paradigm shift in the prevention of retinopathy of prematurity.
For more than 50 years it has been known that oxygen therapy can lead to retinopathy of prematurity (ROP). Recent clinical research has led many neonatologists to lower the target oxygen saturation alarm limits to 85-93% and to titrate the inspired oxygen in small increments. Despite efforts to optimize oxygen therapy, the number of cases of severe ROP remains high as more extremely low birth w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 30 شماره
صفحات -
تاریخ انتشار 2017